Abstract:Highlights • Parthanatos, a type of cell death characterized by its close interaction between the cell nucleus and mitochondria, plays a key role in CNS injury. • Parthanatos are initiated by the over-activation of PARP-1, causing large fragments of DNA and leading to cell death. Other types of cell death could interact with Parthanatos such as apoptosis, autophagy and mitophagy. • In the pathological process of CNS injury, the consequences of damage, such as excitotoxicity and oxidative stress caused by injury, can activate Parthanatos. This cell death pathway can also mediate inflammation and exacerbate the damage. • Parthanatos occurs in different types of cells in CNS injury, including microglia, endothelial cells, oligodendrocytes, astrocytes and neural precursor cells. • Specifically blocking Parthanatos represents a promising novel therapeutic strategy for CNS injury. Background Central nervous system (CNS) injury causes severe organ damage due to both damage resulting from the injury and subsequent cell death. However, there are currently no effective treatments for countering the irreversible loss of cell function. Parthanatos is a poly (ADP-ribose) polymerase 1 (PARP-1)-dependent form of programmed cell death that is partly responsible for neural cell death. Consequently, the mechanism by which parthanatos promotes CNS injury has attracted significant scientific interest. Aim of review Our review aims to summarize the potential role of parthanatos in CNS injury and its molecular and pathophysiological mechanisms. Understanding the role of parthanatos and related molecules in CNS injury is crucial for developing effective treatment strategies and identifying important directions for future in-depth research. Key scientific concepts of review Parthanatos (from Thanatos, the personification of death according to Greek mythology) is a type of programmed cell death that is initiated by the overactivation of PARP-1. This process triggers a cascade of reactions, including the accumulation of poly(ADP-ribose) (PAR), the nuclear translocation of apoptosis-inducing factor (AIF) after its release from mitochondria, and subsequent massive DNA fragmentation caused by migration inhibitory factor (MIF) forming a complex with AIF. Secondary molecular mechanisms, such as excitotoxicity and oxidative stress-induced overactivation of PARP-1, significantly exacerbate neuronal damage following initial mechanical injury to the CNS. Furthermore, parthanatos is not only associated with neuronal damage but also interacts with various other types of cell death. This review focuses on the latest research concerning the parthanatos cell death pathway, particularly considering its regulatory mechanisms and functions in CNS damage. We highlight the associations between parthanatos and different cell types involved in CNS damage and discuss potential therapeutic agents targeting the parthanatos pathway. Graphical abstract Download : Download high-res image (100KB) Download : Download full-size image

[Estimation of the optically active substances in case II water of the lower Jinjiang River based on the bio-optical model].

[Poly Adenosine Diphosphate-Ribosylation and Neurodegenerative Diseases].

Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke

Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches

The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis

Parthanatos And Its Associated Components: Promising Therapeutic Targets For Cancer

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future

Targeting Parthanatos in Ischemic Stroke

The role of PARP1 in neurodegenerative diseases and aging

Blocking the Self‐Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition

Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease

Aggregability of the SQSTM1/p62-based aggresome-like induced structures determines the sensitivity to parthanatos

Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies

Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins

Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α-synuclein degradation via transcription factor EB-dependent autophagy in mutant α-synucleinA53T model of Parkinson's disease

Paraptosis—A Distinct Pathway to Cell Death

Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis

PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson’s disease

Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

Poly ADP-Ribose Signaling is Dysregulated in Huntington Disease Patients

New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase